itnTV

VIDEO: Y90 Embolization of Liver Cancer at Henry Ford Hospital

Interventional Radiology | October 19, 2018

Scott Schwartz, M.D., interventional radiologist and program director for IR residencies and the vascular and interventional radiology fellowship at Henry Ford Hospital, explains how the department uses Yttrium-90 (Y90) embolization therapy to treat liver cancer.

 

Related Articles on Y-90 Radiotherapy:

Current Advances in Targeted Radionuclide Therapy

A Look Ahead in Targeted Radionuclide Therapy

Radioactive Bead Therapy Now Used for Head, Neck Tumors

NCCN Guidelines Recommend Y-90 Microspheres for Metastatic Colorectal Cancer Treatment

 

 

Molecular Imaging

Interventional Radiology | October 19, 2018

Scott Schwartz, M.D., interventional radiologist and program director for IR residencies and the vascular and interventional radiology fellowship at Henry Ford Hospital, explains how the department uses Yttrium-90 (Y90) embolization therapy to treat liver cancer.

 

Related Articles on Y-90 Radiotherapy:

Current Advances in Targeted Radionuclide Therapy

A Look Ahead in Targeted Radionuclide Therapy

Radioactive Bead Therapy Now Used for Head, Neck Tumors

NCCN Guidelines Recommend Y-90 Microspheres for Metastatic Colorectal Cancer Treatment

 

 

Nuclear Imaging | August 24, 2017

Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and president-elect of the American Society of Nuclear Cardiology (ASNC), explained advances in PET and SPECT imaging and the learning curve involved in reading scans from the new CZT SPECT cameras. Watch the VIDEO: Trends in Nuclear Cardiology Imaging, an iknterview with David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida. Read the related article "Advances in Cardiac Nuclear Imaging."

 

Nuclear Imaging | August 24, 2017

Randy Thompson, M.D., attending cardiologist, St. Luke’s Mid-America Heart Institute, Kansas City, explains protocols and what to consider when working with the newer generation CZT-SPECT camera systems for nuclear cardiology. He spoke during the 2017 American Society of Nuclear Cardiology (ASNC) Today technology update meeting. Watch the related VIDEO "PET vs. SPECT in Nuclear Cardiology and Recent Advances in Technology." Read the related articles "Managing Dose in PET and SPECT Myocardial Perfusion Imaging,"  and "Advances in Cardiac Nuclear Imaging."

Clinical Decision Support | June 29, 2017

Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals System, Chicago, discusses the new CMS requirements for clinical decision support (CDS) appropriate use criteria (AUC) documentation in cardiac imaging starting on Jan. 1, 2018. He spoke at the 2017 American Society of Nuclear Cardiology (ASNC) Today meeting. Read the article "CMS to Require Appropriate Use Criteria Documentation for Medical Imaging Orders."

Radiology Business | May 03, 2017

Kim A. Williams, Sr., M.D., chief of cardiology at Rush University Medical Center, Chicago and former president of both the American College of Cardiology (ACC) and the American Society of Nuclear Cardiology (ASNC), explains the impact of healthcare reform on cardiology and specifically on nuclear perfusion imaging. 
 

Nuclear Imaging | April 28, 2017

David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), discusses advancements in nuclear imaging and some of the issues facing the subspecialty.

Radiation Oncology | July 28, 2015

American Association of Physicists in Medicine (AAPM) President John Boone, Ph.D., discusses the impact of imaging in medical physics, as well as key topics addressed at this year’s meeting, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.

Proton Therapy | October 06, 2014

Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of seconds, benefiting from the MEVION S250's direct and efficient beam generation. The result is a fast Pencil Beam Scanning enabling robust Intensity Modulated Proton Therapy treatment delivery that is much less sensitive to patient and tumor motions, ultimately increasing the efficacy of the treatment procedure. The MEVION S250 proton therapy platform with HYPERSCAN allows you to treat with precision, accuracy and reproducibility at unparalleled speed with uncompromised beam quality. Designed for greater access by any size cancer care facility, the MEVION S250 significantly reduces the complexity, size, and cost associated with conventional proton therapy systems. The MEVION S250 is specifically engineered as upgrade-ready to continue providing the most advanced proton therapy treatment available today as well as tomorrow. Key Features : Field-Upgradeable; Streamlined Clinical Workflow with Full OIS Integration; High-Accuracy Beam Pointing with Submillimeter Position Tracking; Fast Volumetric and Layer Rescanning Capabilities; Supports Standard Gating Interface for Beam On/Off Hold

Nuclear Imaging | June 20, 2014

DAIC Editor Dave Fornell shares his choices for the most innovative new technologies in nuclear imaging that were on display at the 2014 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

Nuclear Imaging | June 19, 2014

Satoshi Minoshima, M.D., Ph.D., chairman of the Society of Nuclear Medicine and Molecular Imaging Scientific Committee, discusses the new technologies and trends at SNMMI 2014.

Radiology Imaging | December 13, 2013

ITN Editor Dave Fornell and contributing editor Greg Freiherr discuss some of the most interesting new developments on the show floor at the Radiological Society of North America (RSNA) 2013 annual meeting.

Radiology Imaging | December 03, 2013

Greg Freiherr speaks from the show floor on day three of the 2013 annual meeting of the Radiological Society of North America (RSNA).

Radiation Oncology | August 13, 2013

AAPM President John Hazle, Ph.D., discusses trends in medical physics and major initiatives that the association is addressing in 2014 with Imaging Technology News Editorial Director Melinda Taschetta-Millane.

Neuro Imaging | June 24, 2013

Peter Herscovitch, M.D., SNMMI president-elect, explains the advances in molecular imaging for Alzheimer's disease and Parkinsonian syndromes during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 meeting in Vancouver, Canada. While new agents allow imaging of these disease states, reimbursement and treatment decisions sometimes limit their use.

Nuclear Imaging | June 24, 2013

Gary Dillehay, M.D., FACR, FACNM, SNMMI president, explains some of the trends in Nuclear Imaging at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2013 annual meeting in Vancouver, Canada.

Radiology Imaging | December 14, 2012

ITN Editor Dave Fornell highlights his choices for the most innovative radiology technologies and trends at RSNA 2012. Choices include the first wireless ultrasound transducer, noiseless MRI, a 640-slice CT scanner and a printer than creates sculptures from 3-D datasets.

Nuclear Imaging | July 26, 2012

Speaking with ITN Editorial Director Helen Kuhl at the SNM annual meeting in Miami Beach, Fla., in June, incoming president Frederic H. Fahey, DSc, explains the reasoning behind the society's name change from Society of Nuclear Medicine to Society of Nuclear Medicine and Molecular Imaging. He also shares highlights of the successful 2012 event.

Nuclear Imaging | July 26, 2012

Incoming president Frederic H. Fahey, DSc, describes the primary initiatives the Society of Nuclear Medicine and Molecular Imaging will be undertaking during the coming year, during an interview with ITN Editorial Director Helen Kuhl at the society's annual meeting in June. These include growing global initiatives, including more involvement in developing countries, plus continued education and efforts with regard to radiation dose and dose optimization.

Nuclear Imaging | July 26, 2012

Frederic H. Fahey, DSc, incoming president of the Society of Nuclear Medicine and Molecular Imaging, shares his views about significant trends in the field, including the emergence of new amyloid imaging agents and other new agents, radionuclide therapy and the ongoing focus on quality and safety.